Lisaftoclax

Lisaftoclax (compound 6) is a dual Bcl-2 and Bcl-xl inhibitor with anti-tumor activity, extracted from patent WO2018027097A1. Lisaftoclax exhibits IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl, respectively[1].

Product Specifications

CAS Number

[2180923-05-9]

Product Name Alternative

APG-2575; Bcl-2/Bcl-xl inhibitor 1

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

Bcl-2 Family

Type

Reference compound

Related Pathways

Apoptosis

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/bcl-2-bcl-xl-inhibitor-1.html

Purity

99.28

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(NS(=O)(C1=CC=C(NC[C@@H]2OCCOC2)C([N+]([O-])=O)=C1)=O)C3=CC=C(N4CCN(CC(CC5)=C(C6=CC=C(Cl)C=C6)CC75CCC7)CC4)C=C3OC8=CN=C(NC=C9)C9=C8

Molecular Formula

C45H48ClN7O8S

Molecular Weight

882.42

Precautions

H302, H315, H319

References & Citations

[1]WANG, Chia, et al. N- (PHENYLSULFONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS. Patent. WO2018027097A1.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Phase 3

Isoform

Bcl-2; Bcl-xL

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

283715-01 500 mg

2-Methoxy-4- (4-methylpiperazin-1-yl) aniline

Ask

View Details

283715-02 1 g

2-Methoxy-4- (4-methylpiperazin-1-yl) aniline

Ask

View Details

283715-03 2 g

2-Methoxy-4- (4-methylpiperazin-1-yl) aniline

Ask

View Details

283715-04 5 g

2-Methoxy-4- (4-methylpiperazin-1-yl) aniline

Ask

View Details

AMM09703VCF 100 µg

LIPG Mouse Monoclonal Antibody [Clone ID: LBI4D2]

Ask

View Details

PA17002-01 50 μL

Rabbit Anti-Human TXNDC9 pAb

Ask

View Details